Clinical Use of Measuring Trough Levels and Antibodies against Infliximab in Patients with Pediatric Inflammatory Bowel Disease

BACKGROUND/AIMS: The clinical use of measuring infliximab (IFX) trough levels (TLs) and antibodies against IFX (ATIs) in patients with pediatric inflammatory bowel disease (IBD) remains unclear. We propose measuring these variables to create individual IFX treatment strategies for patients with pedi...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Gut Liver
Hoofdauteurs: Choi, So Yoon, Kang, Ben, Lee, Jee Hyun, Choe, Yon Ho
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Editorial Office of Gut and Liver 2017
Onderwerpen:
Original Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5221861/
https://ncbi.nlm.nih.gov/pubmed/27609485
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5009/gnl16041
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items